Demonstrates improved curcumin release via nanocarrier, suggesting enhanced bioavailability in applications.
High Resolution Image Download MS PowerPoint Slide Curcumin (Cur) is a natural polyphenolic compound with significant therapeutic potential, including antioxidant and anti-inflammatory activities. However, its clinical application is limited by its low aqueous solubility and low bioavailability. In this study, we developed a biocompatible Zn-based metal–organic framework (bio-MOF) as a nanocarrier for curcumin. The synthesized material was characterized by powder X-ray diffraction (P-XRD), fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy with energy dispersive X-ray spectroscopy (SEM-EDS), and thermogravimetric analysis (TG/dTG), confirming the stability of the structure and the successful loading of the drug. The system showed a Cur loading efficiency of 75.98 ± 2.65% ( n = 3). Cytotoxicity assays were performed in MCF-7 cell lines and demonstrated that the delivery system has a superior effect on reducing cell viability compared to free cur. The release kinetics followed a Ritger-Peppas model ( R 2 = 0.948), indicating controlled release behavior. In vitro permeation studies revealed that the carrier successfully penetrated the biomimetic barrier and released Cur in the receptor compartment. Finally, through albumin fluorescence quenching analysis, a progressive decrease in fluorescence was observed with a Stern–Volmer constant ( K SV ) of 9.4 × 10 3 M –1, indicating a moderate binding affinity and suggesting that the nanocarrier can effectively interact with transport proteins. These findings demonstrate that the bio-MOF platform is a promising strategy to enhance the release and biological interaction of hydrophobic phytochemicals.
No takes yet. Share an insight, caveat, or question.
Coelho et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: